文献速递静脉血栓栓塞慢性静脉疾病

妊娠早期蓝肿性绞痛的血栓溶解治疗

Thrombolysis for Management of Phlegmasia Cerulea Dolens in the First Trimester of Pregnancy.
PubMed 文献 · Ann Vasc Surg · 2019-04-19

本文报告一例妊娠早期蓝肿性绞痛患者,采用超声辅助血栓溶解治疗大块髂股深静脉血栓,未使用辐射或造影剂,血管内超声确认静脉系统通畅,母婴安全,患者足月分娩健康婴儿且无后遗症。结论提示对妊娠早期因DVT面临肢体威胁的患者可考虑血管内超声辅助血栓溶解。

要点

  • 妊娠早期蓝肿性绞痛可考虑超声辅助血栓溶解治疗。
  • 治疗中避免辐射和造影剂对胎儿更安全。
  • 血管内超声可确认静脉系统通畅性。

核心结论

  • 对妊娠早期因深静脉血栓面临肢体威胁的患者,可考虑血管内超声辅助的血栓溶解治疗。

研究设计与样本

  • 病例报告:一例妊娠早期蓝肿性绞痛患者接受超声辅助血栓溶解治疗大块髂股深静脉血栓。

主要发现

  • 治疗未使用辐射或造影剂,血管内超声确认整个静脉系统通畅。
  • 患者术后足月分娩健康婴儿,无进一步后遗症。

临床怎么用

  • 妊娠早期蓝肿性绞痛患者,在评估肢体威胁后可考虑超声辅助血栓溶解,以避免辐射和造影剂暴露。

局限性

  • 单例病例报告,证据级别低,结论需更多研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pregnancy is a hypercoagulable state associated with a fivefold increase in the risk of venous thromboembolism. Thrombolysis is the preferred level of care for patients with acute iliofemoral deep vein thrombosis (DVT); however, most studies exclude pregnant patients, highlighting the lack of data regarding the efficacy and safety of thrombolytic therapy for mother and fetus. METHODS: We describe the successful use of thrombolytic therapy in conjunction with ultrasound to remove a large ileofemoral DVT in a first-trimester patient with phlegmasia cerulea dolens. The procedure was performed safely for both mother and fetus. RESULTS: No radiation or contrast dye was used, and intravascular ultrasound confirmed patency of the entirety of the venous system. She delivered a healthy term baby after the procedure and had no further sequalae. CONCLUSION: Thrombolysis with intravascular ultrasound may be considered in first-trimester pregnant patients with threatened limb due to DVT.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dua A, Rothenberg KA, Rao C, et al. Thrombolysis for Management of Phlegmasia Cerulea Dolens in the First Trimester of Pregnancy. Ann Vasc Surg. 2019. PMID: 31009730. doi:10.1016/j.avsg.2019.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。